Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Infection”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Early research (Phase 1)Study completedNCT02262819
What this trial is testing

Human Immunity Against Staphylococcus Aureus Skin Infection

Who this might be right for
Staphylococcus Aureus Skin Infection
National Institute of Allergy and Infectious Diseases (NIAID) 49
Testing effectiveness (Phase 2)Study completedNCT01516749
What this trial is testing

Anakinra as a Treatment for Hydradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
University of California, San Francisco 6
Large-scale testing (Phase 3)Study completedNCT02512614
What this trial is testing

Evaluation of Novel Antimicrobial Hand Towels

Who this might be right for
Diarrheal DiseasesAcute Respiratory InfectionsFever+1 more
Centers for Disease Control and Prevention 449
Early research (Phase 1)Study completedNCT02346760
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers

Who this might be right for
Herpes Simplex Virus Infection
United BioPharma 15
Not applicableStudy completedNCT00829556
What this trial is testing

Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement

Who this might be right for
Prosthetic Joint InfectionSurgical Skin Infection
Rothman Institute Orthopaedics 160
Post-approval studies (Phase 4)Not Yet RecruitingNCT07261072
What this trial is testing

Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS

Who this might be right for
Hidradenitis Suppurativa (HS)Hidradenitis Suppurativa (Acne Inversa)Secukinumab
Peking Union Medical College 30
Testing effectiveness (Phase 2)Study completedNCT01283581
What this trial is testing

Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Melinta Therapeutics, Inc. 256
Post-approval studies (Phase 4)Study completedNCT00352612
What this trial is testing

Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

Who this might be right for
Staphylococcal InfectionAbscessStaphylococcal Skin Infection+1 more
Aaron Chen 200
Large-scale testing (Phase 3)Study completedNCT02582177
What this trial is testing

Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis

Who this might be right for
Tinea
Ache Laboratorios Farmaceuticos S.A. 125
Very early researchLooking for participantsNCT06326476
What this trial is testing

An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

Who this might be right for
Hidradenitis Suppurativa
University of Alabama at Birmingham 12
Large-scale testing (Phase 3)UnknownNCT03131843
What this trial is testing

Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination

Who this might be right for
Skin Infection
University of Toronto 170
Post-approval studies (Phase 4)Study completedNCT02452918
What this trial is testing

Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
The Medicines Company 17
Not applicableNot Yet RecruitingNCT06170983
What this trial is testing

Skin Inflammation and PK of Azithromycin

Who this might be right for
Skin Infection
Medical University of Vienna 36
Testing effectiveness (Phase 2)UnknownNCT05339802
What this trial is testing

A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin Infection
Mabwell (Shanghai) Bioscience Co., Ltd. 90
Not applicableUnknownNCT05868551
What this trial is testing

Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study

Who this might be right for
Onchocercal Subcutaneous NoduleEpilepsyVirus
Universiteit Antwerpen 40
Post-approval studies (Phase 4)Study completedNCT00368537
What this trial is testing

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Who this might be right for
Skin Diseases, Bacterial
Wyeth is now a wholly owned subsidiary of Pfizer 550
Not applicableActive Not RecruitingNCT06796231
What this trial is testing

Efficacy of PD-1 Monoclonal Antibody in the Treatment of Phaeohyphomycosis

Who this might be right for
Phaeohyphomycosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Testing effectiveness (Phase 2)Study completedNCT03637400
What this trial is testing

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

Who this might be right for
Methicillin-resistant Staphylococcus AureusSkin Infection
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 269
Testing effectiveness (Phase 2)WithdrawnNCT02658292
What this trial is testing

Safety and Efficacy of NAFT900 in Children With Tinea Capitis

Who this might be right for
Tinea Capitis
Merz North America, Inc.
Load More Results